We have broad expertise in integrin drug discovery with an extensive publication track record.

• Delivered small molecule integrin inhibitors of clinical quality

• Experience of selecting different routes of administration for integrin inhibitors (oral, iv, inhaled, long acting parenteral)

• Knowledge of selecting the most appropriate integrin tools, probes and standards for biological studies and screening assays

• Application to the treatment of multiple diseases such as fibrosis and cancer

• Up-to-date competitor knowledge and patents